Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
 
(40 intermediate revisions by 6 users not shown)
Line 1: Line 1:
Welcome!
+
Welcome!  
  
*For assignments, please see the "Author" column below.  If no name is present, volunteer to create content!
 
*We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books.  '''<u>If there is an entity not yet listed below that you would like to author in any WHO book, we would be happy to create a page for you now</u>'''.
 
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
 
*'''<u>NOTE: A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated by mid-2023; we're working on a plan to align the related CCGA content to the new structure.</u>'''
 
  
__TOC__
+
We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books.  Please join the effort!   
  
==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content==
 
{| class="wikitable"
 
|-
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
 
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
 
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''!!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|-
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|Fabiola Quintero-Rivera (FQR)
 
|Date page was created
 
|
 
|-
 
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
 
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|FQR
 
|Date page was created
 
|
 
|-
 
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
 
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|FQR
 
|Date page was created
 
|
 
|-
 
|    Polycythaemia Vera  (PV)||Disease
 
|Gokce A. Toruner
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Primary Myelofibrosis  (PMF)||Disease
 
|T. Niroshi  Senaratne
 
|
 
|
 
|complete
 
|
 
|FQR
 
|8/4/2020 before submission
 
|
 
|-
 
|    Essential  Thrombocythaemia (ET)||Disease
 
|Rebecca Smith
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
|Chelsea D. Kramish (trainee), Daynna J.Wolff
 
|
 
|
 
|complete/pending faculty review
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
|Thomas Lee
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
 
|
 
|
 
|complete
 
| ||FQR
 
|
 
|
 
|-
 
|    Cutaneous  Mastocytosis||Disease
 
|Thuy Phung + Shuo-Shawn Liu (trainee)
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Systemic Mastocytosis||Disease
 
|Shashi Shetty
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Mast Cell Sarcoma||Disease
 
|Thuy Phung +Jordan Lowery (trainee)
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
 
|Disease
 
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|NON-WHO ENTITY
 
|-
 
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
 
|Disease
 
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|NON-WHO ENTITY
 
|-
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 
|
 
|9/1/20
 
|PENDING importing content and reference formatting
 
|
 
|FQR
 
|
 
|FQR has emailed SR several times, last 4/20/22
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|FQR
 
|Date page was created
 
|
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Jack Reid (trainee)+Fabiola Quintero-Rivera
 
|
 
|4/21/22
 
|pending
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
 
|
 
|9/1/20
 
|PENDING
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|9/1/20
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|9/1/20
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|Myelodysplastic Neoplasm with Biallelic TP53 Inactivation
 
|Disease
 
|Eric McGinnis
 
|
 
|5/4/23
 
|PENDING
 
| ||FQR
 
|
 
|'''Page New in 5th Edition of Book'''. 2021 template added.
 
|-
 
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 
|
 
|
 
|Complete
 
|
 
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
 
|04/26/2021 -MS (re-review)
 
|
 
|-
 
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
 
|
 
|
 
|''<s>PENDING</s> Complete - awaiting clarification''
 
| ||JH / MS
 
|04/26/2021 -MS (re-review)
 
|Review completed, awaiting some clarification from JH - 07/04/2022
 
|-
 
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS
 
|
 
|-
 
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
 
|
 
|
 
|Complete
 
|02/03/2021||JH / MS
 
|
 
|
 
|-
 
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/02/2021-MS
 
|
 
|-
 
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/02/2021-MS (re-review)
 
|
 
|-
 
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|04/26/2021 -MS (re-review)
 
|
 
|-
 
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 
|
 
|
 
|Complete
 
|
 
|JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|04/26/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|02/24/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Need permission for figure?  Update WHO?
 
|-
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
 
Corboy (Monash Health)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Add WHO reference
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Check reference format
 
|-
 
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Need permission for figure?
 
|-
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Check reference format
 
|-
 
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
 
|
 
|
 
|PENDING
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
 
|
 
|
 
|PENDING
 
| ||JH / MS
 
|
 
|
 
|-
 
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
 
|Disease
 
|Kay Weng Choy + Greg Corboy (Monash Health)
 
|
 
|
 
|Complete
 
|
 
|JH / MS
 
|
 
|NON-WHO ENTITY
 
|-
 
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
 
|Disease
 
|Daynna Wolff+Jessica Snider (Path Resident)
 
|
 
|
 
|PENDING
 
|
 
|JH / MS
 
|
 
|NON-WHO ENTITY
 
|-
 
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
 
|Disease
 
|Daynna Wolff+ Paige Woodham (Path Resident)
 
|
 
|
 
|PENDING
 
|
 
|JH / MS
 
|
 
|NON-WHO ENTITY
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Holli Drendel (HD)
 
|
 
|YA (prior AE)
 
|-
 
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 
|
 
|
 
|PENDING
 
|
 
|HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
 
  
Lisa Smith + Yassmine Akkari
+
To volunteer:  
|
 
|
 
|Complete
 
|
 
|HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
|
 
|HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
 
|
 
|
 
|Complete
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
 
|Disease
 
|Diana Rush
 
|
 
|
 
|PENDING
 
|
 
|HD
 
|
 
|YA (prior AE); NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
 
|Disease
 
|Celeste Eno
 
|
 
|
 
|PENDING
 
|
 
|HD
 
|
 
|YA (prior AE); NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
 
|Disease
 
|Marilena Melas
 
|
 
|
 
|PENDING
 
|
 
|HD
 
|
 
|YA (prior AE); NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
 
|Disease
 
|Chenkai Ma
 
|
 
|
 
|PENDING
 
|
 
|HD
 
|
 
|YA (prior AE); NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
 
|Disease
 
|Celeste Eno
 
|
 
|
 
|PENDING
 
|
 
|HD
 
|
 
|YA (prior AE); NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
 
|Disease
 
|Alaa Koleilat
 
|
 
|
 
|PENDING
 
|
 
|HD
 
|
 
|YA (prior AE); NON-WHO ENTITY
 
|-
 
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE)
 
|-
 
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE); 2021 template added
 
|-
 
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
 
|
 
|
 
|PENDING
 
| ||HD
 
|
 
|YA (prior AE); 2021 template added
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Shivani Golem (SG)
 
|
 
|SP (prior AE)
 
|-
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Jaime Nagy, PhD/
 
  
Renee Eigsti, MD
+
#Select a link in the table to your book(s) of interest to view specific authorship opportunitiesAdditional books are in the process of being added.
|
+
#'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interest.  You will be connected with an Associate Editor to help guide you through the process.
|
+
#Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentialsInformation on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available.
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE); NOTE TO BAILEY: author updating page on staging server with conversion to new template (small amount of content on older template with 4th edition content - need to convert to new template and update to 5th edition content). Then transfer to production server when ready.
 
|-
 
|       Monoclonal B-cell Lymphocytosis||Disease||Tsigab Bahta Hagos (trainee) / Shashirekha Shetty
 
|12/19/2022
 
|1/19/2023
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE), 2021 template added
 
|-
 
|B-cell Prolymphocytic Leukemia||Disease||
 
|
 
|
 
|
 
|
 
|SG
 
|
 
|SP (prior AE); 2021 template added; No longer an entity
 
|-
 
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|Hairy Cell Leukemia||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|Lymphoplasmacytic Lymphoma||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
|
 
|SG
 
|4/12/2023 by FQR
 
|SP (prior AE); 2021 template added
 
|-
 
|   Waldenstrom  Macroglobulinemia||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
|
 
|SG
 
|4/12/2023 by FQR
 
|SP (prior AE); 2021 template added
 
|-
 
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
 
|
 
|
 
|
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|    Mu Heavy Chain  Disease||Disease||
 
|
 
|
 
|
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
 
|
 
|
 
|Complete
 
|5/26/2021||SG
 
|
 
|SP (prior AE)
 
|-
 
|    Alpha Heavy Chain  Disease||Disease||
 
|
 
|
 
|
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
|
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
|
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
 
|
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|    Plasmacytoma||Disease||Zhenya Tang
 
|
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
 
|
 
|
 
|Complete
 
|09/10/2022||SG
 
|
 
|SP (prior AE)
 
|-
 
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
 
|
 
|
 
|?PENDING
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|           Light Chain and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
 
|
 
|
 
|Complete
 
|10/15/2022||SG
 
|
 
|SP (prior AE)
 
|-
 
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
 
|8/31/2021
 
|9/15/2021
 
|PENDING
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
 
|
 
|
 
|?PENDING
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
 
|
 
|
 
|?PENDING
 
| ||SG
 
|
 
|SP (prior AE)
 
|-
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
|
 
|SG
 
|4/12/23 by FQR
 
|SP (prior AE); 2021 template added
 
|-
 
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
 
|
 
|
 
|Complete
 
|5/28/2021||SG
 
|
 
|SP (prior AE)
 
|-
 
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|
 
|
 
|Complete
 
|11/11/2020
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|Follicular Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau
 
|7/28/2024
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE); has prior content in old template but same name in 5th edition - Rachel working on this outside of production site with new template to replace production site page later)
 
|-
 
|    Testicular Follicular Lymphoma|| ||to be deleted
 
|
 
|
 
|
 
|
 
|
 
|
 
|TO BE DELETED - NOT IN 5th EDITION
 
|-
 
|    In Situ Follicular Neoplasia||Disease||Rachel Burnside
 
|7/28/2023
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE); 2021 template added (no prior content; name to 5th edition version of In Situ Follicular B-cell Neoplasm will be changed later but Rachel working on 5th edition content in this production site)
 
|-
 
|    Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside
 
|7/28/2023
 
|
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE); 2021 template added (name same in 5th edition version and no prior content; Rachel working on 5th edition content in this production site)
 
|-
 
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|
 
|
 
|Complete
 
|8/16/2020
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
 
|
 
|9/30/20
 
|Complete
 
|5/26/2021||SG
 
|
 
|SP (prior AE)
 
|-
 
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
 
|
 
|
 
|Complete
 
|09/10/2022
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|
 
|8/15/20
 
|PENDING
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Tsigab Hagos (trainee)/Shashirekha.Shetty
 
|12/19/2022
 
|1/19/2022
 
|Pending
 
|
 
|SG
 
|
 
|SP (prior AE)
 
|-
 
|    In Situ Mantle Cell  Neoplasia||Disease||Rina Kansal, MD
 
|6/12/22
 
|
 
|Complete
 
|7/26/2022
 
|SG
 
|
 
|SP (prior AE); 2021 template added
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
 
|
 
|
 
|PENDING
 
|
 
|Greg Corboy (GC)
 
|
 
|Requested to update 14022022
 
|-
 
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
 
|26/10/2021
 
|26/1/2022
 
|Complete
 
|03/28/22||GC
 
|03/28/22
 
|2021 template added
 
|-
 
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|EBV-Positive Mucocutaneous Ulcer||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Lymphomatoid Granulomatosis||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
 
|25/01/2022
 
|25/4/2022
 
|Complete
 
|9/1/22||GC
 
|9/1/22
 
|Emailed 28/3/2022 for progress update
 
|-
 
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando (fellow), Fabiola Quintero-Rivera
 
|
 
|
 
|PENDING
 
| ||GC
 
|
 
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added. FQR emailed Manando on 4/12/23
 
|-
 
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
| ||GC
 
|28/03/2022
 
|
 
|-
 
|Primary Effusion Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
 
|10/26/2021
 
|1/26/2022
 
|Complete
 
|24/01/2022||GC
 
|24/01/2022
 
|2021 template added
 
|-
 
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Xiao Zhou, MD, PhD, Siparadigm
 
|10/26/2021
 
|1/26/2022
 
|PENDING
 
| ||GC
 
|
 
|Emailed 28/3/2022 for progress update
 
|-
 
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Xiao Zhou, MD, PhD, Siparadigm
 
|10/26/2021
 
|1/26/2022
 
|PENDING
 
| ||GC
 
|
 
|Emailed 28/3/2022 for progress update
 
|-
 
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
 
|3/11/21
 
|06/28/2021
 
|Complete
 
|28/06/2021||GC
 
|28/06/2021
 
|
 
|-
 
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
 
|10/13/21
 
|01/13/2022
 
|Complete
 
|27/01/2022
 
|GC
 
|27/01/2021
 
|2021 template added
 
|-
 
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
 
|30/05/21
 
|30/08/21
 
|Complete
 
|24/02/2022||GC
 
|24/02/2022
 
|
 
|-
 
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
 
|7/30/21
 
|10/30/21
 
|Complete
 
|15/11/2021
 
|GC
 
|16/11/2021
 
|
 
|-
 
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Sumi Kitahara (SK)
 
|
 
|SP (prior AE)
 
|-
 
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
 
|
 
|
 
|?PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
 
|
 
|
 
|Complete
 
|11/21/2021||SK
 
|
 
|SP (prior AE)
 
|-
 
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|    Severe Mosquito Bite  Allergy||Disease||
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
 
|
 
|
 
|?PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|Complete
 
|9/26/2022
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|Complete
 
|1/21/2021
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
|
 
|
 
|PENDING
 
|
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|Complete
 
|9/26/2022
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
 
|
 
|
 
|Complete
 
|1/21/2021
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Bo Hong
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE); 2021 template added
 
|-
 
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau, Sara Akhavanfard (trainee)
 
|7/28/2023
 
|
 
|PENDING
 
|
 
|SK
 
|
 
|SP (prior AE); (has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type)
 
|-
 
|    Follicular T-cell  Lymphoma||Disease||Rachel Burnside
 
|7/28/2023
 
|
 
|PENDING
 
|
 
|SK
 
|
 
|SP (prior AE); 2021 template added (name to 5th edition version of Nodal TFH Cell Lymphoma, Follicular-Type will be changed later but Rachel working on 5th edition content in this production site)
 
|-
 
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
 
|
 
|
 
|PENDING
 
| ||SK
 
|
 
|SP (prior AE)
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara / Miguel Gonzalez (trainee)
 
|
 
|
 
|Completed
 
|09/23/2022
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara  / Miguel Gonzalez (trainee)
 
|
 
|
 
|Completed
 
|09/23/2022
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
|
 
|
 
|PENDING
 
|
 
|SK
 
|
 
|SP (prior AE)
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Greg Corboy (GC)
 
|
 
|
 
|-
 
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||Thomas Harrington (resident) + Daynna Wolff
 
|06/22/2022
 
|09/22/2022
 
|PENDING
 
| ||GC
 
|
 
|2021 template added, Daynna organising
 
|-
 
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
 
|
 
|
 
|Completed
 
|03/21/22||GC
 
|03/21/22
 
|Edits sent 14022022
 
|-
 
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|
 
|
 
|PENDING
 
| ||GC
 
|
 
|2021 template added
 
|-
 
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|
 
|
 
|PENDING
 
| ||GC
 
|
 
|2021 template added
 
|-
 
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|
 
|
 
|PENDING
 
| ||GC
 
|
 
|2021 template added
 
|-
 
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|11/2/21
 
|02/02/22
 
|Completed
 
|03/21/22
 
|GC
 
|03/21/22
 
|2021 template added
 
|-
 
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Ania Shestakova (trainee) + Fabiola Quintero-Rivera
 
|
 
|
 
|completed
 
|april 2022
 
|GC
 
|26/4/2022
 
|
 
|-
 
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|          Monomorphic  B-cell PTLD||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|          Monomorphic  T/NK-cell PTLD||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
 
|
 
|
 
|Complete
 
|10/01/2021
 
|GC
 
|10/01/2021
 
|Xinjie Xu
 
|-
 
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
 
|02/01/2022
 
|05/01/2022
 
|Complete
 
|04/28/2022||GC
 
|5/19/2022
 
|
 
|-
 
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
 
|02/01/2022
 
|05/01/2022
 
|Complete
 
|04/28/2022||GC
 
|5/19/2022
 
|
 
|-
 
|Indeterminate Dendritic Cell Tumour||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Interdigitating Dendritic Cell Sarcoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Follicular Dendritic Cell Sarcoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Fibroblastic Reticular Cell Tumor||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Disseminated Juvenile Xanthogranuloma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Erdheim-Chester Disease||Disease||Prashant Deshpande
 
|02/02/2022
 
|05/02/2022
 
|PENDING
 
| ||GC
 
|
 
|emailed 28/3/2022 to get update
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|}<br />
 
  
==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
 
{| class="wikitable"
 
|-
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
 
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
 
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''!!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|-
 
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
 
|2/20/2022
 
|
 
|PENDING
 
|
 
|Alanna Church
 
|
 
|
 
|-
 
|}<br />
 
  
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
 
 
{| class="wikitable"
 
{| class="wikitable"
 +
|+BOOKS WITH CONTENT IN PROGRESS
 +
!Book Name
 +
!Book Edition
 +
!Book Acronym
 
|-
 
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
+
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
!'''Date Assigned to Author'''
+
|5th
!'''Target Completion Date'''
+
|HAEM5
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''!!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
 
|-
 
|-
|Astrocystoma, IDH-Mutant
+
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
|Disease
+
|5th
|Meenakshi Mehrotra
+
|CNS5
|6/25/2023
 
|
 
|PENDING
 
|
 
|Laveniya Satgunaseelan (LS)
 
|
 
|2021 template added
 
 
|-
 
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
+
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
|6/7/2022
+
|5th
|
+
|GTS5
|COMPLETE
 
|
 
|LS
 
|
 
|2021 template added
 
 
|-
 
|-
|Glioblastoma, IDH-Wildtype||Disease||Madina Sukhanova
+
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
|
+
|5th
|
+
|BRST5
|PENDING
 
|
 
|LS
 
|
 
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
 
 
|-
 
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
+
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
|6/27/2023
+
|5th
|
+
|STBT5
|PENDING
+
|}
|
+
 
|LS
+
 
|
 
|2021 template added (page created 6/27/23)
 
|-
 
|Angiocentric Glioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Diffuse Midline Glioma, H3  K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
 
|
 
|
 
|PENDING
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
 
|2/21/2022
 
|
 
|COMPLETE
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
 
|10/28/2022
 
|
 
|COMPLETE
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|Infant-Type Hemispheric Glioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|2021 template added
 
|-
 
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
 
|9/13/2022<br />
 
|
 
|PENDING
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|High-Grade Astrocytoma with Piloid Features||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pleomorphic Xanthoastrocytoma||Disease||
 
|
 
|
 
|
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|Subependymal Giant Cell Astrocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Chordoid Glioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Astroblastoma, MN1-Altered||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Ganglioglioma||Disease||Leila Moayed-Aloei
 
|6/30/2022
 
|
 
|COMPLETE
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|Gangliocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Dysembryoplastic Neuroepithelial Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Papillary Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Rosette-Forming Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Myxoid Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Multinodular and Vacuolating Neuronal Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Central Neurocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Extraventricular Neurocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Cerebellar Liponeurocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Supratentorial Ependymoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Posterior Fossa Ependymoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Spinal Ependymoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Spinal Ependymoma, MYCN-Amplified||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Myxopapillary Ependymoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Subependymoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Choroid Plexus Papilloma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Atypical Choroid Plexus Papilloma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Choroid Plexus Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 
|9/20/21
 
|
 
|COMPLETE
 
|
 
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 
|9/22/2022
 
|2021 template added
 
|-
 
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Medulloblastoma, Histologically Defined||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Atypical Teratoid/Rhabdoid Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Cribriform Neuroepithelial Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Embryonal Tumour with Multilayered Rosettes||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CNS Neuroblastoma, FOXR2-Activated||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CNS Embryonal Tumour NEC/NOS||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pineocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pineoblastoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Papillary Tumour of the Pineal Region||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Schwannoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Neurofibroma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Perineurioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Hybrid Nerve Sheath Tumours||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Malignant Melanotic Nerve Sheath Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Malignant Peripheral Nerve Sheath Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Meningioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Solitary Fibrous Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Haemangiomas and Vascular Malformations||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Haemangioblastoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Rhabdomyosarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CIC-Rearranged Sarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Ewing Sarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Mesenchymal Chondrosarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Chondrosarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Chordoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Immunodeficiency-Associated CNS Lymphomas||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Lymphomatoid Granulomatosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Intravascular Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MALT Lymphoma of the Dura||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
 
|7/2/2023
 
|
 
|PENDING
 
|
 
|MS
 
|
 
|2021 template added
 
|-
 
|T-cell and NK/T-cell Lymphomas||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Erdheim-Chester Disease||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Rosai-Dorfman Disease||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Juvenile Xanthogranuloma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Langerhans Cell Histiocytosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Histiocytic Sarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Germ Cell Tumours of the CNS||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Adamantinomatous Craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Papillary Craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pituitary Blastoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Metastases to the Meninges||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
 
|
 
|
 
|
 
|
 
|
 
|
 
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|Neurofibromatosis Type 2||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Schwannomatosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Von Hippel-Lindau Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Tuberous Sclerosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Li-Fraumeni Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Cowden Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
 
|7/2/2023
 
|
 
|PENDING
 
|
 
|LS
 
|
 
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|Familial Adenomatous Polyposis 1||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Rhabdoid Tumour Predisposition Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Carney Complex||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|DICER1 Syndrome||Disease||Jennie Thurston
 
|7/2/2023
 
|
 
|PENDING
 
|
 
|LS
 
|
 
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|Familial Paraganglioma Syndromes||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Melanoma-Astrocytoma Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Familial Retinoblastoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|BAP1 Tumour Predisposition Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Fanconi Anaemia||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|ELP1-Medulloblastoma Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|}<br />
 
==WHO Classification of Tumours of the Breast (5th Edition) Content==
 
 
{| class="wikitable"
 
{| class="wikitable"
 +
|+BOOKS COMING SOON
 +
!Book Name
 +
!Book Edition
 +
!Book Acronym
 
|-
 
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
+
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
!'''Date Assigned to Author'''
+
|5th
!'''Target Completion Date'''
+
|DIG5
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''!!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|- |Usual ductal hyperplasia||Disease||
 
|Usual Ductal Hyperplasia
 
|Disease
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Atypical Ductal Hyperplasia||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Sclerosing Adenosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Apocrine Adenosis and Adenoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Microglandular Adenosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Radial Scar/Complex Sclerosing Lesion||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Tubular Adenoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Lactating Adenoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Ductal Adenoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pleomorphic Adenoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Adenomyoepithelioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Malignant Adenomyoepithelioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Intraductal Papilloma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Papillary Ductal Carcinoma In Situ||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Encapsulated Papillary Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Invasive Papillary Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Atypical Lobular Hyperplasia||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Lobular Carcinoma In Situ||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Ductal Carcinoma In Situ||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Invasive Breast Carcinoma of No Special Type||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Microinvasive Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Invasive lobular Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Tubular Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Cribriform Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Mucinous Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Mucinous Cystadenocarcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Invasive Micropapillary Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Carcinoma with Apocrine Differentiation||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Metaplastic Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Acinic Cell Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach
 
|10/12/02022
 
|
 
|PENDING
 
|
 
|Hui Chen
 
|
 
|2021 template added
 
|-
 
|Secretory Carcinoma||Disease||Hui Chen
 
|10/12/2022
 
|
 
|PENDING
 
|
 
|Katherine Geiersbach
 
|
 
|2021 template added
 
|-
 
|Mucoepidermoid Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Polymorphous Adenocarcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Tall Cell Carcinoma with Reversed Polarity||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Neuroendocrine Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Neuroendocrine Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Hamartoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Fibroadenoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Phyllodes Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Syringomatous Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Nipple Adenoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Paget disease of the Breast||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Haemangioma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Angiomatosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Atypical Vascular Lesions||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Postradiation Angiosarcoma of the Breast||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Primary Angiosarcoma of the Breast||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Nodular Fasciitis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Myofibroblastoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Desmoid Fibromatosis||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Inflammatory Myofibroblastic Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Schwannoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Neurofibroma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Granular Cell Tumour||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Leiomyoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Leiomyosarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Lipoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Angiolipoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Liposarcoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Pseudoangiomatous Stromal Hyperplasia||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Follicular Lymphoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Diffuse Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Burkitt Lymphoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Gynaecomastia||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Carcinoma In Situ||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Invasive Carcinoma||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Metastases to the Breast||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Cowden Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Ataxia-Telangiectasia||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CDH1-Associated Breast Cancer||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|PALB2-Associated Cancers||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Peutz-Jeghers Syndrome||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
 
|
 
|
 
|
 
|
 
|
 
|
 
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|Polygenic Component of Breast Cancer Susceptibility
 
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|}<br />
 
==Genetic Tumour Syndromes (5th Edition) Content==
 
{| class="wikitable"
 
|-
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
 
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
 
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''!!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|-
 
|Constitutional Mismatch Repair Deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)||Disease||Jennie Thurston
 
|7/2/2023
 
|
 
|
 
|
 
|LS
 
|
 
|Named based on GTS5 book
 
|-
 
|DICER1-Related Tumour Predisposition Syndrome (DICER1)
 
|Disease
 
|Jennie Thurston
 
|7/2/2023
 
|
 
|
 
|
 
|LS
 
|
 
|Named based on GTS5 book
 
|-
 
|Neurofibromatosis Type 1 (NF1)
 
|Disease
 
|Ngoni Faya (trainee) + Madina Sukhanova
 
|7/12/2023
 
|
 
|
 
|
 
|Madina Sukhanova (Madina S)
 
|
 
|Named based on GTS5 book
 
|-
 
|}<br />
 
 
 
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
 
{| class="wikitable sortable"
 
!'''Gene'''
 
!'''Author'''
 
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
 
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''
 
!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|-
 
|BCR
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/10/18
 
|
 
|
 
|
 
|-
 
|ABL1
 
|Brian Davis
 
|
 
|
 
|Complete
 
|4/16/19
 
|
 
|
 
|
 
|-
 
|RUNX1
 
|Brian Davis
 
|
 
|
 
|Complete
 
|6/9/19
 
|
 
|
 
|
 
|-
 
|RUNX1T1
 
|Brian Davis
 
|
 
|
 
|Complete
 
|5/23/19
 
|
 
|
 
|
 
|-
 
|MYH11
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/6/18
 
|
 
|
 
|
 
|-
 
|FLT3
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|NPM1
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|TP53
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|DNMT3A
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|CEBPA
 
|Gordana
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|IDH1
 
|Paul De Fazio
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|IDH2
 
|Paul De Fazio
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|PML
 
|Brian Davis
 
|
 
|
 
|Complete
 
|12/5/18
 
|
 
|
 
|
 
|-
 
|RARA
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/3/18
 
|
 
|
 
|
 
|-
 
|ETV6
 
|Brian Davis
 
|
 
|
 
|Complete
 
|6/9/19
 
|
 
|
 
|
 
|-
 
|KIT
 
|Brian Davis
 
|
 
|
 
|Complete
 
|10/1/18
 
|
 
|
 
|
 
|-
 
|CBFB
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/2/18
 
|
 
|
 
|
 
|-
 
|GATA2
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|PTEN
 
|Beth Pitel
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|MLTT3
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MECOM
 
|Brian Davis
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|FGFR1(FLT2)
 
|Brian Davis
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|KMT2A
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|DEK
 
|Wahab A. Khan
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|NUP214
 
|Wahab A. Khan
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|RBM15
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MKL1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|DDX41
 
|Ying Zou
 
|8/7/20
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|ANKRD26
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CUX1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|TET2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|EZH2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|FOXP1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MYC
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|JAK2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|WT1
 
|DONE
 
|
 
|
 
|DONE
 
|
 
|
 
|
 
|
 
|-
 
|CBL
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|NF1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|SUZ12
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|ERG
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|EST2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|RPS14
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|RB1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MPL
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CHGA
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CDH1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|SRSF2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|DNMT1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|PRDX2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|ASXL1
 
|DONE
 
|
 
|
 
|DONE
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|MN1
+
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
|
+
|5th
|
+
|EYE5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|SF3A1
+
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
|
+
|5th
|
+
|SKIN5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|EP300
+
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
|
+
|5th
|
+
|HAN5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|JARID2
+
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
|
+
|5th
|
+
|ENDO5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|BRCA1
+
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
|
+
|5th
|
+
|MALE5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|BRCA2
+
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
|
+
|5th
|
+
|PEDS5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|
+
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
|
+
|5th
|
+
|THOR5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|
+
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
|
+
|5th
|
+
|FEMA5
|
 
|
 
|
 
|
 
|
 
|
 
 
|}
 
|}

Latest revision as of 12:29, 27 June 2024

Welcome!


We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort!


To volunteer:

  1. Select a link in the table to your book(s) of interest to view specific authorship opportunities. Additional books are in the process of being added.
  2. Contact us with your disease page of interest. You will be connected with an Associate Editor to help guide you through the process.
  3. Complete the brief Volunteer Form to receive your log-in credentials. Information on Authorship and Other Roles with the CCGA is available.


BOOKS WITH CONTENT IN PROGRESS
Book Name Book Edition Book Acronym
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 5th HAEM5
WHO Classification of Tumours of the Central Nervous System 5th CNS5
WHO Classification of Genetic Tumour Syndromes 5th GTS5
WHO Classification of Tumours of the Breast 5th BRST5
WHO Classification of Soft Tissue and Bone Tumours 5th STBT5


BOOKS COMING SOON
Book Name Book Edition Book Acronym
WHO Classification of Digestive System Tumours 5th DIG5
WHO Classification of Eye and Orbit Tumours 5th EYE5
WHO Classification of Skin Tumours 5th SKIN5
WHO Classification of Head and Neck Tumours 5th HAN5
WHO Classification of Endocrine and Neuroendocrine Tumours 5th ENDO5
WHO Classification of Urinary and Male Genital Tumours 5th MALE5
WHO Classification of Paediatric Tumours 5th PEDS5
WHO Classification of Thoracic Tumours 5th THOR5
WHO Classification of Female Genital Tumours 5th FEMA5